Xeris Biopharma Holdings
XERS
XERS
86 hedge funds and large institutions have $85M invested in Xeris Biopharma Holdings in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
22.83% more ownership
Funds ownership: 62.51% → 85.34% (+23%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $685K
Holders
86
Holding in Top 10
1
Calls
–
Puts
$685K
Top Buyers
| 1 | +$7.04M | |
| 2 | +$2.89M | |
| 3 | +$2.66M | |
| 4 |
SC
Sessa Capital
New York
|
+$2.5M |
| 5 |
Millennium Management
New York
|
+$1.34M |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$1.25M | |
| 3 | -$762K | |
| 4 |
Renaissance Technologies
New York
|
-$751K |
| 5 |
DM
Deerfield Management
New York
|
-$678K |